106 filings
Page 5 of 6
8-K
dgdux
12 Nov 21
Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
7:00am
8-K
mbrx9af
4 Nov 21
Other Events
4:02pm
8-K
en9an3mnk1a1q
2 Nov 21
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction
4:02pm
8-K
i5t5u
12 Aug 21
Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
10:35am
10-Q
zwoem3 j08gvj8wdr
14 Jun 21
Quarterly report
4:21pm
8-K
soa1iaf
14 Jun 21
Talaris Therapeutics Announces First Quarter 2021 Financial Results and Provides Business
4:07pm
8-K
ldgztwzclpqi
11 May 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
424B4
bvs0duytxmvdyiekhs
10 May 21
Prospectus supplement with pricing info
4:20pm
EFFECT
15rakcu3mz 7i
7 May 21
Notice of effectiveness
12:15am
S-8
nhp9r9i74287
6 May 21
Registration of securities for employees
4:37pm
CERT
35jfkxih2aaxks
6 May 21
Certification of approval for exchange listing
4:31pm
SEC STAFF
hlbcj6
6 May 21
SEC staff action: Order
12:00am
UPLOAD
22ijnh qia
5 May 21
Letter from SEC
12:00am
8-A12B
rzjr72 as2mp6
4 May 21
Registration of securities on exchange
4:04pm
CORRESP
32rvzk1gzqbig087cd
4 May 21
Correspondence with SEC
12:00am
CORRESP
j3mfff8ta7 mg
4 May 21
Correspondence with SEC
12:00am
S-1/A
fcyimhwts 026ue5rddd
3 May 21
IPO registration (amended)
6:07am
S-1
3je5eq5 48
16 Apr 21
IPO registration
5:03pm
CORRESP
9mnyo2 zxkgsn4
16 Apr 21
Correspondence with SEC
12:00am